Disclosed are compounds of Formula I, or pharmaceutically acceptable salts thereof, wherein W, X, Y, Z, R1, R2, R3, R4 and R5 are as described in this application, and methods of using said compounds in the treatment of cancer.
申请公布号
MX2016006432(A)
申请公布日期
2016.07.19
申请号
MX20160006432
申请日期
2014.11.14
申请人
F. HOFFMANN-LA ROCHE AG
发明人
ROBERT FRANCIS KESTER;YAN LOU;SHAOQING CHEN;CHRISTOPHE MICHOUD;STACY REMISZEWSKI;ANDREW F. DONNELL;KANG LE;KENNETH C. RUPERT;MARTIN WEISEL
